Insulin-Like Growth Factor 1 (Wright State Physicians)

胰岛素样生长因子-1(Wright State Physicians)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInsulin-Like Growth Factor 1 (Wright State Physicians)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInsulin-like growth factor I receptor agonists
TargetsInsulin-like growth factor I receptor
Therapy Area/IndicationsNasolabial fold wrinklesHealthy AgingSunburn
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesWright State Physicians
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNasolabial fold wrinklesHealthy AgingSunburn
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A